The following article contains an error: 'A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE^-/-^ mouse model' by Tracey Gaspari, HongBin Liu, Iresha Welungoda, Yunshan Hu, Robert E Widdop, Lotte B Knudsen, Richard W Simpson and Anthony E Dear, published in *Diabetes & Vascular Disease Research* 2011; 8(2): 117--124, DOI: 10.1177/1479164111404257.

The following corrections apply:

Page 121, left column, the third paragraph, beginning 'No significant change...', should be replaced with the following text:

A small but significant decrease in body weight and trend to reduction in systolic blood pressure was noted in the liraglutide treated groups (data shown below).

![Data in relation to body weight and systolic blood pressure from the four-week in vivo study.\
\*p\<0.05, liraglutide group before treatment commenced vs liraglutide group after treatment commenced.](10.1177_1479164111426971-fig1){#fig1-1479164111426971}

The authors apologize for this error.
